CorMedix Inc.CRMDNASDAQ
Loading
Operating Income Growth Under PressureDecelerating
Percentile Rank74
5Y CAGR+14.0%
Year-over-Year Change
Year-over-year operating income growth rate
5Y CAGR
+14.0%/yr
Long-term compound
Percentile
P74
Within normal range
vs 5Y Ago
1.9x
Solid growth
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | 15.15% |
| Q3 2025 | 162.73% |
| Q2 2025 | -2.89% |
| Q1 2025 | 55.58% |
| Q4 2024 | 493.51% |
| Q3 2024 | 78.52% |
| Q2 2024 | 8.40% |
| Q1 2024 | -6.61% |
| Q4 2023 | -49.69% |
| Q3 2023 | 11.33% |
| Q2 2023 | -7.15% |
| Q1 2023 | -31.33% |
| Q4 2022 | -20.50% |
| Q3 2022 | 15.52% |
| Q2 2022 | -17.18% |
| Q1 2022 | 9.61% |
| Q4 2021 | 9.17% |
| Q3 2021 | -45.61% |
| Q2 2021 | 18.42% |
| Q1 2021 | -18.50% |
| Q4 2020 | 7.86% |
| Q3 2020 | 25.97% |
| Q2 2020 | -58.96% |
| Q1 2020 | -4.37% |
| Q4 2019 | -3.97% |
| Q3 2019 | 6.61% |
| Q2 2019 | -12.48% |
| Q1 2019 | -330.25% |
| Q4 2018 | 120.88% |
| Q3 2018 | -19.47% |
| Q2 2018 | 15.87% |
| Q1 2018 | 0.80% |
| Q4 2017 | -28.19% |
| Q3 2017 | -14.09% |
| Q2 2017 | 7.83% |
| Q1 2017 | -18.50% |
| Q4 2016 | 29.79% |
| Q3 2016 | -86.43% |
| Q2 2016 | -15.27% |
| Q1 2016 | -84.48% |